Urine test could guide diabetes meds to prevent organ damage
NCT ID NCT06954090
First seen Jan 07, 2026 · Last updated Jun 23, 2026 · Updated 29 times
Summary
This study explores whether a urine protein test can help doctors personalize treatment for people with type 2 diabetes. Researchers will give participants two drugs—semaglutide (Ozempic) and finerenone—and see if the test results help decide who needs which medication. The goal is to prevent heart and kidney complications. The study involves 50 adults with type 2 diabetes and no severe heart failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALBUMINURIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Steno Diabetes Center Copenhagen
Herlev, Hajdú-Bihar, 2730, Denmark
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Semaglutide (Ozempic) and Finerenone
What this could lead to
If successful, this could show that simple urine tests help doctors choose the right medications to prevent heart and kidney damage in people with type 2 diabetes.
What could go wrong
This is a small, early feasibility study with only 50 participants, so results may not apply to everyone. The focus is on testing the process, not proving the treatments work.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.